Quick Answer
CNBX Pharmaceuticals Inc. reported Stockholders Equity of -$2.50 million for fiscal year 2025.
CNBX Pharmaceuticals Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$2.50M | -0.7% |
| 2024 | -$2.48M | -22.9% |
| 2023 | -$2.02M | -223.6% |
| 2022 | $1.63M | -9.6% |
| 2021 | $1.81M | +2.3% |
| 2020 | $1.76M | -88.0% |
| 2019 | $14.74M | +457.3% |
| 2018 | $2.65M | +190.0% |
| 2017 | -$2.94M | -528.7% |
| 2016 | -$467.4K | -51.0% |
| 2015 | -$309.6K | -872.5% |
| 2014 | $40.1K | +138.0% |
| 2013 | -$105.4K | -115.1% |
| 2012 | -$49.0K | -3.5% |
| 2011 | -$47.3K | -178.9% |
| 2010 | $60.0K | -65.7% |
| 2009 | $174.9K | -39.6% |
| 2008 | $289.9K | -8.7% |
| 2007 | $317.3K | +119.7% |
| 2006 | $144.4K | +11394.0% |
| 2005 | -$1.3K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$2.57M | -2.3% | -3.1% |
| August 31, 2025 | -$2.50M | -0.7% | +1.6% |
| May 31, 2025 | -$2.54M | -3.4% | +1.3% |
| February 28, 2025 | -$2.57M | -9.0% | -2.2% |
| November 30, 2024 | -$2.51M | -20.0% | -1.4% |
| August 31, 2024 | -$2.48M | -22.9% | -1.0% |
| May 31, 2024 | -$2.45M | -28.5% | -4.1% |
| February 29, 2024 | -$2.36M | -17.3% | -12.6% |
- CNBX Pharmaceuticals Inc. showed a decrease of -0.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2005–2025 period, CNBX Pharmaceuticals Inc.’s stockholders equity has declined by 195075.4% (from -$1.3 thousand to -$2.50 million).
- The most recent figure is from CNBX Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: